Christian Grommes, MD

Christian Grommes, MD, is a neuro-oncologist and associate attending physician at Memorial Sloan Kettering Cancer Center.

Articles by Christian Grommes, MD

$Christian Grommes, MD, discusses how BTK inhibitors and CAR T-cell therapy fit into the relapsed/refractory primary CNS lymphoma treatment paradigm.$

Dr Grommes on Treatment Approaches in R/R PCNSL

ByChristian Grommes, MD

July 3rd 2026

Christian Grommes, MD, discusses how BTK inhibitors and CAR T-cell therapy fit into the relapsed/refractory primary CNS lymphoma treatment paradigm.

Dr Grommes on the Addition of Ibrutinib to R-MPV Induction in Newly Diagnosed PCNSL

ByChristian Grommes, MD

November 24th 2025

Christian Grommes, MD, shares results from a phase 2 study evaluating ibrutinib plus rituximab, methotrexate, vincristine, and procarbazine in PSNCL.

Latest Updated Articles

Dr Grommes on the Addition of Ibrutinib to R-MPV Induction in Newly Diagnosed PCNSL
November 24th 2025

Christian Grommes, MD

Articles by Christian Grommes, MD

Dr Grommes on Treatment Approaches in R/R PCNSL

Dr Grommes on the Addition of Ibrutinib to R-MPV Induction in Newly Diagnosed PCNSL

Latest Updated Articles

Trending on OncLive

Dr Orloff on Key Findings From the Phase 2/3 OptimUM-02 Trial in Uveal Melanoma

Study Identifies RNA Surveillance Defect That Fuels Melanoma Through Endogenous Retroviral RNA

Luspatercept Sustains Long-Term Transfusion Independence, Favorable OS Trend in ESA-Naive Lower-Risk MDS

Belantamab Mafodotin Yields Sustained MRD Negativity in R/R Myeloma

FDA Grants Breakthrough Device Designation to Merlin CP-GEP for Early-Stage Melanoma Risk Stratification